Radiotherapy is a common treatment for men with prostate cancer, particular in combination with androgen deprivation. However, various factors can limit the dose of radiation that can be administered, so the effect might be suboptimal. In this Review, the authors discuss how radiotherapy could be optimized by combining with other treatments in a multimodal approach, particularly in the setting of oligometastatic disease.
- Yiannis Philippou
- Hanna Sjoberg
- Richard J. Bryant
